Oxford BioTherapeutics News and Activities

Oxford BioTherapeutics is a company listed under the stock ticker OXB (GB).

View the org chart displaying its 16 main executives

Most searched biographies at Oxford BioTherapeutics

• Christian Rohlff, Chief Executive Officer
• Jason Gould, Non-Executive Director
• Jean-Pierre Bizzari, Non-Executive Director

Create your alert
to follow the executive moves at Oxford BioTherapeutics.

Oxford BioTherapeutics has 2,426 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Archimed Group has acquired Esperion Therapeutics (posted on July 14 2026).
• The new name of ChemoTech is Neem’s Hill. (posted on July 14 2026).
• MindRank has just announced a $52 Million fundraising (posted on July 14 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Oxford BioTherapeutics

• Immunotherapies Expose and Exploit Cancer’s Varied Weaknesses
• www.oxfordbiotherapeutics.com/news.html

Social media about Oxford BioTherapeutics

• Oxford BioTherapeutics on Wikipedia, Google News & Yahoo Finance
• Oxford BioTherapeutics on LinkedIn, X (Twitter) & YouTube